38338-20-4 Usage
Uses
Used in Pharmaceutical Development:
4-bromo-6-chlorobenzo[d]thiazol-2-amine is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical structure and bioactive properties make it a valuable component in the development of new drugs and treatments for various medical conditions.
Used in Agrochemical Development:
4-bromo-6-chlorobenzo[d]thiazol-2-amine is also used in the development of agrochemicals, such as pesticides and herbicides. Its chemical properties and potential biological activities can contribute to the creation of effective and environmentally friendly solutions for agricultural applications.
Used in Medicinal Chemistry Research:
4-bromo-6-chlorobenzo[d]thiazol-2-amine is used as a research compound in medicinal chemistry. Its promising bioactive properties and potential therapeutic applications make it an interesting subject for further investigation and exploration in the field of drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 38338-20-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,3,3 and 8 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 38338-20:
(7*3)+(6*8)+(5*3)+(4*3)+(3*8)+(2*2)+(1*0)=124
124 % 10 = 4
So 38338-20-4 is a valid CAS Registry Number.
InChI:InChI=1/C7H4BrClN2S/c8-4-1-3(9)2-5-6(4)11-7(10)12-5/h1-2H,(H2,10,11)
38338-20-4Relevant academic research and scientific papers
PBr3-mediated unexpected reductive deoxygenation of α-aryl-pyridinemethanols: Synthesis of arylmethylpyridines
Nishigaya, Yosuke,Umei, Kentaro,Watanabe, Daisuke,Kohno, Yasushi,Seto, Shigeki
supporting information, p. 1566 - 1572 (2016/03/01)
PBr3-mediated reductive deoxygenation of α-aryl-pyridinemethanols to provide arylmethylpyridines is described, the alcohol substrate scope is explored, free radical trap TEMPO (2,2,6,6-tetramethyl-1-piperidinyloxy) is introduced, and the hydrogen source of the methylene product is defined. The unexpected reaction enabled us to prepare previously inaccessible, novel EP1 antagonists.
